Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 1/20 | 0.47 |
| ▸ | CA7 | P43166 | 1/20 | 0.47 |
| ▸ | CA9 | Q16790 | 1/20 | 0.47 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.47 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.43 |
| ▸ | LMNA | P02545 | 2/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.43 |
| ▸ | SIRT2 | Q8IXJ6 | 1/20 | 0.42 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.42 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.42 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | HTT | P42858 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.41 |
| ▸ | IDO1 | P14902 | 1/20 | 0.40 |
| ▸ | TSHR | P16473 | 2/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2642315 | 0.83 | CYP4F2 (0.47) | CA12CA7CA9CA14ALDH1A1 | |
| SCHEMBL27350489 | 0.83 | TDP1 (0.40) | CA12CA7CA14TDP1ALDH1A1 | |
| SCHEMBL28816810 | 0.81 | ALDH1A1 (0.60) | TDP1ALDH1A1LMNAKDM4EMAPT | |
| Methyl 3-Phenylpropanoate SCHEMBL27447160 | 0.80 | TDP1 (0.66) | CA12CA7CA9CA14TDP1 | |
| SCHEMBL5262959 | 0.80 | HDAC2 (0.43) | ALDH1A1LMNAKDM4EMAPTHTT | |
| SCHEMBL1419158 | 0.79 | KEAP1 (0.61) | ALDH1A1MAPT | |
| SCHEMBL995727 | 0.79 | CYP4F2 (0.46) | CA12CA7CA9CA14TDP1 | |
| Methyl 3-Phenylpropanoate SCHEMBL168711 | 0.78 | TDP1 (0.68) | CA12CA7CA9CA14TDP1 | |
| SCHEMBL4819068 | 0.78 | KDM4E (0.59) | ALDH1A1LMNAKDM4EKMT2A | |
| Methyl 3-Phenylpropanoate SCHEMBL1893702 | 0.77 | TDP1 (0.66) | CA12CA7CA9CA14TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2791120-B1 | 1,3,5 -TRIAZINE-2-AMINE DERIVATIVES, PREPARATION THEREOF AND DIAGNOSTIC AND THERAPEUTIC USE THEREOF | SANOFI SA (FR) | 2016-02-24 | — | — | EP | claimed |
| US-9115121-B2 | 1,3,5-triazine-2-amine derivatives, preparation thereof and diagnostic and therapeutic use thereof | SANOFI (FR) | 2015-08-25 | — | — | US | claimed |
| US-20140343061-A1 | 1,3,5 -Triazine-2-Amine Derivatives, Preparation Thereof And Diagnostic And Therapeutic Use Thereof | SANOFI (FR) | 2014-11-20 | — | — | US | claimed |
| EP-2791120-A1 | 1,3,5 -TRIAZINE-2-AMINE DERIVATIVES, PREPARATION THEREOF AND DIAGNOSTIC AND THERAPEUTIC USE THEREOF | SANOFI (FR) | 2014-10-22 | — | — | EP | claimed |
| WO-2013087643-A1 | 1,3,5 -TRIAZINE-2-AMINE DERIVATIVES, PREPARATION THEREOF AND DIAGNOSTIC AND THERAPEUTIC USE THEREOF | SANOFI (FR) | 2013-06-20 | — | — | WO | claimed |
| US-7314511-B2 | Metaloxyphthalocyanine compounds | FUJIFILM IMAGING COLORANTS LIMITED (GB) | 2008-01-01 | — | — | US | claimed |
| CN-100345912-C | Metaloxyphthalocyanine compounds | AVECIA LTD (GB) | 2007-10-31 | — | — | CN | claimed |
| EP-1537181-B1 | METALOXYPHTHALOCYANINE COMPOUNDS | FUJIFILM IMAGING COLORANTS LTD (GB) | 2007-05-02 | — | — | EP | claimed |
| US-20060000388-A1 | Metaloxyphthalocyanine compounds | AVECIA INKJET LIMITED (GB) | 2006-01-05 | — | — | US | claimed |
| CN-1678691-A | Metaloxyphthalocyanine compounds | AVECIA LTD (GB) | 2005-10-05 | — | — | CN | claimed |
| EP-1537181-A1 | METALOXYPHTHALOCYANINE COMPOUNDS | Avecia Limited (GB) | 2005-06-08 | — | — | EP | claimed |
| WO-2004020529-A1 | METALOXYPHTHALOCYANINE COMPOUNDS | AVECIA LIMITED (GB) | 2004-03-11 | — | — | WO | claimed |
| EP-2791120-B1 | 1,3,5 -TRIAZINE-2-AMINE DERIVATIVES, PREPARATION THEREOF AND DIAGNOSTIC AND THERAPEUTIC USE THEREOF | SANOFI SA (FR) | 2016-02-24 | — | — | EP | disclosed |
| US-9115121-B2 | 1,3,5-triazine-2-amine derivatives, preparation thereof and diagnostic and therapeutic use thereof | SANOFI (FR) | 2015-08-25 | — | — | US | disclosed |
| US-20140343061-A1 | 1,3,5 -Triazine-2-Amine Derivatives, Preparation Thereof And Diagnostic And Therapeutic Use Thereof | SANOFI (FR) | 2014-11-20 | — | — | US | disclosed |
| EP-2791120-A1 | 1,3,5 -TRIAZINE-2-AMINE DERIVATIVES, PREPARATION THEREOF AND DIAGNOSTIC AND THERAPEUTIC USE THEREOF | SANOFI (FR) | 2014-10-22 | — | — | EP | disclosed |
| US-20060000388-A1 | Metaloxyphthalocyanine compounds | AVECIA INKJET LIMITED (GB) | 2006-01-05 | — | — | US | disclosed |
| CN-1678691-A | Metaloxyphthalocyanine compounds | AVECIA LTD (GB) | 2005-10-05 | — | — | CN | disclosed |
| EP-1537181-A1 | METALOXYPHTHALOCYANINE COMPOUNDS | Avecia Limited (GB) | 2005-06-08 | — | — | EP | disclosed |
| WO-2004020529-A1 | METALOXYPHTHALOCYANINE COMPOUNDS | AVECIA LIMITED (GB) | 2004-03-11 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140343061-A1 | 1,3,5 -Triazine-2-Amine Derivatives, Preparation Thereof And Diagnostic And Therapeutic Use Thereof | ALK, HRH3, HRH4 | CA12 562/4885CA7 219/4885CA9 1104/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.